1 |
Celli B,Fabbri L,Criner G,et al.Definition and nomenclature of chronic obstructive pulmonary disease:Time for its revision[J].Am J Respir Crit Care Med,2022,206(11):1317-1325.
|
2 |
Guerreiro I,Soccal PM.COPD and phenotypes[J].Rev Med Suisse,2019,15(671):2082-2086.
|
3 |
Bagdonas E,Raudoniute J,Bruzauskaite I,et al.Novel aspects of pathogenesis and regeneration mechanisms in COPD[J].Int J Chron Obstruct Pulmon Dis,2015,10:995-1013.
|
4 |
GBD Chronic Respiratory Disease Collaborators.Prevalence and attributable health burden of chronic respiratory diseases,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet Respir Med,2020,8(6):585-596.
|
5 |
GBD 2015 Chronic Respiratory Disease Collaborators.Global,regional,and national deaths,prevalence,disability-adjusted life years,and years lived with disability for chronic obstructive pulmonary disease and asthma,1990-2015:A systematic analysis for the Global Burden of Disease Study 2015[J].Lancet Respir Med,2017,5(9):691-706.
|
6 |
Yin P,Wu J,Wang L,et al.The burden of COPD in China and its provinces:Findings from the Global Burden of Disease Study 2019[J].Front Public Health,2022,10:859499.
|
7 |
Lozano R,Naghavi M,Foreman K,et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010[J].Lancet,2016,380(9859):2095-2128.
|
8 |
Hu W,Fang L,Zhang H,et al.Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China[J].Public Health,2022,208:89-97.
|
9 |
Smith MC,Wrobel JP.Epidemiology and clinical impact of major comorbidities in patients with COPD[J].Int J Chron Obstruct Pulmon Dis,2014,9:871-888.
|
10 |
Mathers CD,Loncar D.Projections of global mortality and burden of disease from 2002 to 2030[J].PLoS Med,2006,3(11):e442.
|
11 |
GBD 2021 Diseases and Injuries Collaborators.Global incidence,prevalence,years lived with disability (YLDs),disability-adjusted life-years (DALYs),and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations,1990-2021:A systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440):2133-2161.
|
12 |
赵军一,赵 凤,曲冰佳,等.1990-2019 年中国类风湿性关节炎疾病负担现状和趋势分析[J].中国卫生统计,2024,41(3):344-348,353.
|
13 |
Organization WH.ICD-10:International statistical classification of diseases and related health problems :tenth revision[J].Acta Chir Iugosl,2010,56(3):65-69.
|
14 |
张荣强,李凤英.年估计百分比变化与平均增长速度在公共卫生领域中的应用比较[J].中国卫生统计,2015,32(2):328-329,332.
|
15 |
Zhang L,Tong Z,Han R,et al.Spatiotemporal trends in global burden of rheumatic heart disease and associated risk factors from 1990 to 2019[J].Int J Cardiol,2023,384:100-106.
|
16 |
Zhang T,Sun L,Yin X,et al.Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035:results from the GBD study[J].BMC Public Health,2024,24(1):1639.
|
17 |
Halpin DMG,Celli BR,Criner GJ,et al.The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries[J].Int J Tuberc Lung Dis,2019,23(11):1131-1141.
|
18 |
Meghji J,Mortimer K,Agusti A,et al.Improving lung health in low-income and middle-income countries:from challenges to solutions[J].Lancet,2021,397(10277):928-940.
|
19 |
GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death,1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2015,385(9963):117-171.
|
20 |
Christenson SA,Smith BM,Bafadhel M,et al.Chronic obstructive pulmonary disease[J].Lancet,2022,399(10342):2227-2242.
|
21 |
Mannino DM,Buist AS.Global burden of COPD:risk factors,prevalence,and future trends[J].Lancet,2007,370(9589):765-773.
|
22 |
Safiri S,Carson-Chahhoud K,Noori M,et al.Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories,1990-2019:results from the Global Burden of Disease Study 2019[J].BMJ,2022,378:e069679.
|
23 |
Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey[J].Am J Respir Crit Care Med,2007,176(8):753-60.
|
24 |
Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study):A national cross-sectional study [J].Lancet,391(10131):1706-1717.
|
25 |
Hu W,Fang L,Zhang H,et al.Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China[J].Public health,2022,208:89-97.
|
26 |
Menezes AM,Perez-Padilla R,Jardim JR,et al.PLATINO Team.Chronic obstructive pulmonary disease in five Latin American cities(the PLATINO study):a prevalence study[J].Lancet,2005,366(9500):1875-1881.
|
27 |
任成山,王关嵩,钱桂生.慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD].中华肺部疾病杂志(电子版),2019,12(2):127-141.
|